Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Oncodesign and TiumBio collaborate to discover and develop candidates for fibrosis

Oct. 21, 2021

BNIP3L is a molecular target in mitophagy defects and mitochondrial dysfunction

Oct. 14, 2021

A large-scale analysis of loss of imprinting in naive and primed human pluripotent stem cells

Oct. 7, 2021

Sweet taste of success for asymmetric organocatalysis

Oct. 6, 2021

Nobel Prize for Red Hot Chili Pepper and Cool Mint receptors

Oct. 4, 2021

GSK-852 identified as a soluble BET inhibitor selective for BD2

Sep. 30, 2021

BeiGene discovers non-receptor tyrosine-protein kinase TYK2 inhibitors

Sep. 23, 2021

New IL-17 modulators identified at UCB

Sep. 23, 2021

New necroptosis inhibitors synthesized at Anaxis Pharma

Sep. 22, 2021

Dual SYK/VEGFR2 inhibitors discovered at Ocumension Therapeutics

Sep. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...